{"id":"https://openalex.org/W2129397990","doi":"https://doi.org/10.1158/2326-6066.cir-14-0059","title":"Association Studies of Fc\u03b3 Receptor Polymorphisms with Outcome in HER2+ Breast Cancer Patients Treated with Trastuzumab in NCCTG (Alliance) Trial N9831","display_name":"Association Studies of Fc\u03b3 Receptor Polymorphisms with Outcome in HER2+ Breast Cancer Patients Treated with Trastuzumab in NCCTG (Alliance) Trial N9831","publication_year":2014,"publication_date":"2014-07-03","ids":{"openalex":"https://openalex.org/W2129397990","doi":"https://doi.org/10.1158/2326-6066.cir-14-0059","mag":"2129397990","pmid":"https://pubmed.ncbi.nlm.nih.gov/24989892","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4215796"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.cir-14-0059","doi":"https://doi.org/10.1158/2326-6066.cir-14-0059","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.cir-14-0059","pdf_url":"https://aacrjournals.org/cancerimmunolres/article-pdf/2/10/962/2344606/962.pdf","source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/cancerimmunolres/article-pdf/2/10/962/2344606/962.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023752531","display_name":"Nadine Norton","orcid":"https://orcid.org/0000-0002-3848-4288","observed_orcids":["https://orcid.org/0000-0002-3848-4288"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nadine Norton","raw_affiliation_strings":["1Mayo Clinic, Jacksonville, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mayo Clinic, Jacksonville, Florida","institution_ids":["https://openalex.org/I4210146710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006838765","display_name":"Rebecca M. Olson","orcid":"https://orcid.org/0000-0002-2714-9409","observed_orcids":["https://orcid.org/0000-0002-2714-9409"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca M. Olson","raw_affiliation_strings":["2Stanford University, Stanford, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Stanford University, Stanford, California","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030502460","display_name":"Mark Daniel Pegram","orcid":"https://orcid.org/0000-0002-9743-8118","observed_orcids":["https://orcid.org/0000-0002-9743-8118"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Pegram","raw_affiliation_strings":["2Stanford University, Stanford, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Stanford University, Stanford, California","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085436504","display_name":"Kathleen Tenner","orcid":"https://orcid.org/0000-0003-4607-4286","observed_orcids":["https://orcid.org/0000-0003-4607-4286"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathleen Tenner","raw_affiliation_strings":["3Mayo Clinic, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Mayo Clinic, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074015095","display_name":"Karla V. Ballman","orcid":"https://orcid.org/0000-0002-4492-0357","observed_orcids":["https://orcid.org/0000-0002-4492-0357"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karla V. Ballman","raw_affiliation_strings":["3Mayo Clinic, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Mayo Clinic, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088476266","display_name":"Raphael Clynes","orcid":"https://orcid.org/0000-0002-7963-8482","observed_orcids":["https://orcid.org/0000-0002-7963-8482"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Raphael Clynes","raw_affiliation_strings":["4Columbia University, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Columbia University, New York, New York","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031005364","display_name":"Keith L. Knutson","orcid":"https://orcid.org/0000-0001-9932-4467","observed_orcids":["https://orcid.org/0000-0001-9932-4467"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210131476","display_name":"Vaccine & Gene Therapy Institute of Florida","ror":"https://ror.org/03ez2en98","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210131476"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Keith L. Knutson","raw_affiliation_strings":["3Mayo Clinic, Rochester, Minnesota","5Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Mayo Clinic, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"5Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, Florida","institution_ids":["https://openalex.org/I4210131476"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065306642","display_name":"Edith A. Perez","orcid":"https://orcid.org/0000-0002-5037-6677","observed_orcids":["https://orcid.org/0000-0002-5037-6677","https://orcid.org/0000-0001-7009-7467"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Edith A. Perez","raw_affiliation_strings":["1Mayo Clinic, Jacksonville, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mayo Clinic, Jacksonville, Florida","institution_ids":["https://openalex.org/I4210146710"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5031005364","https://openalex.org/A5065306642","https://openalex.org/A5088476266"],"corresponding_institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210131476","https://openalex.org/I4210146710","https://openalex.org/I78577930"],"apc_list":null,"apc_paid":null,"fwci":3.2763,"has_fulltext":true,"cited_by_count":49,"citation_normalized_percentile":{"value":0.93511438,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"2","issue":"10","first_page":"962","last_page":"969"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.951200008392334,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.951200008392334,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.014600000344216824,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.009600000455975533,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fc-gamma-receptor-polymorphisms","display_name":"Fc gamma receptor polymorphisms","score":0.9229999780654907},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9539999961853027},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":1.0},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.9539999961853027},{"id":"https://openalex.org/keywords/adjuvant-trastuzumab","display_name":"adjuvant trastuzumab","score":0.7680000066757202},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.609000027179718},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.5839999914169312}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.9020380973815918},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7836088538169861},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.658100426197052},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6190537214279175},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.602392852306366},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.5851407051086426},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5432941913604736},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.49366626143455505},{"id":"https://openalex.org/C31467283","wikidata":"https://www.wikidata.org/wiki/Q912147","display_name":"Genotyping","level":4,"score":0.48328402638435364},{"id":"https://openalex.org/C160798450","wikidata":"https://www.wikidata.org/wiki/Q4230870","display_name":"Concordance","level":2,"score":0.41336894035339355},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2877369523048401},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.10491552948951721},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1011614203453064},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08379456400871277},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005787","descriptor_name":"Gene Frequency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015810","descriptor_name":"Linkage Disequilibrium","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017452","descriptor_name":"Receptors, IgG","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020641","descriptor_name":"Polymorphism, Single Nucleotide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1158/2326-6066.cir-14-0059","doi":"https://doi.org/10.1158/2326-6066.cir-14-0059","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.cir-14-0059","pdf_url":"https://aacrjournals.org/cancerimmunolres/article-pdf/2/10/962/2344606/962.pdf","source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},{"id":"pmid:24989892","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24989892","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer immunology research","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4215796","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4215796","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Cancer Immunol Res","raw_type":"Text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.868.5891","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.868.5891","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://cancerimmunolres.aacrjournals.org/content/2/10/962.full.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.877.9350","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.877.9350","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://cancerimmunolres.aacrjournals.org/content/early/2014/07/02/2326-6066.CIR-14-0059.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1158/2326-6066.cir-14-0059","doi":"https://doi.org/10.1158/2326-6066.cir-14-0059","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.cir-14-0059","pdf_url":"https://aacrjournals.org/cancerimmunolres/article-pdf/2/10/962/2344606/962.pdf","source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3600754640","display_name":"Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab","funder_award_id":"5r01ca152045-05","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G606979843","display_name":null,"funder_award_id":"R01-CA1520-45","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6127403653","display_name":"North Central Cancer Treatment Group","funder_award_id":"U10CA025224","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8740451518","display_name":"Alliance for Clinical Trials in Oncology Operations Center","funder_award_id":"U10CA180821","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000108059","display_name":null,"funder_award_id":"R01-CA152045","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000322517","display_name":null,"funder_award_id":"CA25224","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000866180","display_name":"Mayo Clinic Comprehensive Cancer Center Support Grant","funder_award_id":"P30CA015083","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000872750","display_name":"The Alliance NCTN Biorepository and Biospecimen Resource","funder_award_id":"U24CA196171","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2129397990.pdf","grobid_xml":"https://content.openalex.org/works/W2129397990.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1817930542","https://openalex.org/W1825768998","https://openalex.org/W1989410511","https://openalex.org/W1991071047","https://openalex.org/W2000276387","https://openalex.org/W2028000100","https://openalex.org/W2032161105","https://openalex.org/W2037007095","https://openalex.org/W2075901113","https://openalex.org/W2086542713","https://openalex.org/W2096884232","https://openalex.org/W2098775844","https://openalex.org/W2100527196","https://openalex.org/W2105692976","https://openalex.org/W2122080125","https://openalex.org/W2127404828","https://openalex.org/W2128402413","https://openalex.org/W2132095426","https://openalex.org/W2136527721","https://openalex.org/W2138523530","https://openalex.org/W2146384083","https://openalex.org/W2149908785","https://openalex.org/W2162530578","https://openalex.org/W2162904392","https://openalex.org/W2327593719"],"related_works":["https://openalex.org/W7098907047","https://openalex.org/W2381088668","https://openalex.org/W2162904392","https://openalex.org/W2546973056","https://openalex.org/W1445806932","https://openalex.org/W2100527196","https://openalex.org/W2814801779","https://openalex.org/W7100276764","https://openalex.org/W1889879569","https://openalex.org/W1969826104"],"abstract_inverted_index":{"Patients":[0,93,103],"with":[1,6,14,17,27,48,57,65,117,198,209],"HER2+":[2],"breast":[3],"cancer":[4],"treated":[5,16,116],"trastuzumab":[7,120,204,258],"and":[8,23,40,68,81,110,119,125,133,171,184,186,224,243],"chemotherapy":[9,18,101,118],"have":[10],"superior":[11],"survival":[12,141],"compared":[13,139,208],"patients":[15,62,87,158,172,200],"alone.":[19],"Polymorphisms":[20],"within":[21,146],"FCGR2A":[22,79,166,185],"FCGR3A":[24,77,162,183],"are":[25],"associated":[26,47],"binding":[28],"affinity":[29],"of":[30,38,54,256],"natural":[31],"killer":[32],"cells":[33],"to":[34],"the":[35,76,89,161,210,249],"IgG1":[36],"portion":[37],"trastuzumab,":[39],"a":[41,191],"polymorphism":[42],"in":[43,85,94,104,122,127,154,193],"FCGR2B":[44,82,196,222,250],"(I232T)":[45],"is":[46,63],"impaired":[49],"regulatory":[50],"activity.":[51],"The":[52,219],"association":[53,238],"these":[55],"polymorphisms":[56,84],"clinical":[58,91],"response":[59],"among":[60,143],"trastuzumab-treated":[61,157],"equivocal,":[64],"both":[66],"positive":[67],"negative":[69],"associations.":[70],"We":[71,150],"performed":[72],"genotyping":[73],"analysis":[74,233],"on":[75],"V158F,":[78],"R131H,":[80],"I232T":[83],"1,325":[86],"from":[88,203],"N9831":[90],"trial.":[92],"arm":[95,123,128],"A":[96],"(N":[97,107,112],"=":[98,108,113,217,230],"419)":[99],"received":[100],"only.":[102],"arms":[105,148],"B":[106,124],"469)":[109],"C":[111],"437)":[114],"were":[115],"(sequentially":[121],"concurrently":[126],"C).":[129],"Using":[130],"log-rank":[131],"test":[132],"Cox":[134],"proportional":[135],"hazard":[136],"models,":[137],"we":[138],"disease-free":[140],"(DFS)":[142],"genotypic":[144],"groups":[145],"pooled":[147],"B/C.":[149],"found":[151],"no":[152,179],"differences":[153],"DFS":[155,194],"between":[156,182,221,239],"who":[159,213],"had":[160],"158":[163],"V/V":[164],"and/or":[165],"131":[167],"H/H":[168],"high-affinity":[169,241],"genotypes":[170,242],"without":[173],"those":[174],"genotypes.":[175],"Furthermore,":[176],"there":[177,189],"was":[178,190,226],"significant":[180,228],"interaction":[181,220],"treatment.":[187],"However,":[188,245],"difference":[192],"for":[195],"I232T,":[197],"I/I":[199],"deriving":[201],"benefit":[202],"(P":[205,216,229],"<":[206],"0.001),":[207],"T":[211],"carriers":[212],"did":[214,234],"not":[215,235],"0.81).":[218],"genotype":[223],"treatment":[225],"statistically":[227],"0.03).":[231],"Our":[232],"reveal":[236],"an":[237],"Fc\u03b3R":[240],"outcomes.":[244],"it":[246],"seems":[247],"that":[248],"inhibitory":[251],"gene":[252],"may":[253],"be":[254],"predictive":[255],"adjuvant":[257],"benefit.":[259]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":4}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}